Table 1: Distribution of probiotic species evaluated in terms of efficacy with respect to the control group, in all consensus studies.
|
Bacterial Species |
Nº of studies (%) |
Significant reduction in Sm (%) |
Significant increase in salivary pH/ buffer capacity |
Significant increase in salivary level of sIgA |
Average treatment time in days |
|
L. rhamnosus |
5 (25%) |
3 (60%) |
2 (40%) |
0 |
68,7 days |
|
L. paracasei |
6 (30%) |
5 (83,3%) |
1 (16,6%) |
1 (16,6%) |
128,5 days |
|
L. reuteri |
3 (15%) |
1 (33,3%) |
1 (33,3%) |
0 |
147,6 days |
|
L. acidophilus |
2 (10%) |
2 (100%) |
0 |
0 |
22 days |
|
L. casei |
1 (5%) |
1 (100%) |
0 |
0 |
57 days |
|
L. sporogenes |
1 (5%) |
1 (100%) |
0 |
0 |
30 days |
|
Bacillus coagulans |
2 (10%) |
1 (50%) |
0 |
0 |
10,5 days |
|
Bifidobacterium lactis |
1 (5%) |
1 (100%) |
0 |
0 |
14 days |
|
Streptococcus salivarius |
1 (5%) |
1 (100%) |
0 |
0 |
91,2 days |